The historical rank and industry rank for Accelerate Diagnostics's Equity-to-Asset or its related term are showing as below:
STU:1A80'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.06 Med: 0.21 Max: 0.96
Current: -0.84
During the past 13 years, the highest Equity to Asset Ratio of Accelerate Diagnostics was 0.96. The lowest was -1.06. And the median was 0.21.
STU:1A80's Equity-to-Asset is ranked worse than 95.19% of 873
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs STU:1A80: -0.84
Accelerate Diagnostics Equity-to-Asset Historical Data
The historical data trend for Accelerate Diagnostics's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Accelerate Diagnostics's Equity-to-Asset
For the Medical Devices subindustry, Accelerate Diagnostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accelerate Diagnostics's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Accelerate Diagnostics's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Accelerate Diagnostics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Accelerate Diagnostics Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Accelerate Diagnostics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Accelerate Diagnostics (STU:1A80) Business Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:1A80 has been successfully added to your 